StockData
BeyondSpring Inc. logo

BeyondSpring Inc. (BYSI) stock

BYSINasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 4/30
$0.56−0.02 (-3.27%)

Close on Nov 17, 2026Market cap $23.02MP/E –Yield –

BeyondSpring revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

BeyondSpring's revenue for the twelve months ending Jun 30, 2026 was $0. For fiscal 2025 it was $0. The highest annual figure on record is $1.35M in fiscal 2021.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$0–
FY2024Dec 31, 2024$0–
FY2023Dec 31, 2023$0-100.0%
FY2022Dec 31, 2022$1.35M0.0%
FY2021Dec 31, 2021$1.35M+650.6%
FY2020Dec 31, 2020$180.00K–
FY2019Dec 31, 2019$0–
FY2018Dec 31, 2018$0–
FY2017Dec 31, 2017$0–
FY2016Dec 31, 2016$0–
FY2015Dec 31, 2015$0–
FY2014Dec 31, 2014$0–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$0–
Q1 FY2026Mar 31, 2026$0–
Q4 FY2025Dec 31, 2025$0–
Q3 FY2025Sep 30, 2025$0–
Q2 FY2025Jun 30, 2025$0–
Q1 FY2025Mar 31, 2025$0–
Q4 FY2024Dec 31, 2024$0-100.0%
Q3 FY2024Sep 30, 2024$0-100.0%
Q2 FY2024Jun 30, 2024$0-100.0%
Q1 FY2024Mar 31, 2024$0-100.0%
Q4 FY2021Dec 31, 2021$338.00K+87.8%
Q3 FY2021Sep 30, 2021$337.00K–
Q2 FY2021Jun 30, 2021$338.00K–
Q1 FY2021Mar 31, 2021$338.00K–
Q4 FY2020Dec 31, 2020$180.00K–
Q3 FY2020Sep 30, 2020$0–
Q2 FY2020Jun 30, 2020$0–
Q4 FY2019Dec 31, 2019$0–
Q3 FY2019Sep 30, 2019$0–
Q2 FY2019Jun 30, 2019$0–
Q1 FY2019Mar 31, 2019$0–
Q2 FY2018Jun 30, 2018$0–
Q1 FY2018Mar 31, 2018$0–
Q2 FY2017Jun 30, 2017$0–
Q1 FY2017Mar 31, 2017$0–

More BeyondSpring figures

See a number that looks wrong?